Targeting of MiR-20a Against CFLAR to Potentiate TRAIL-induced Apoptotic Sensitivity in HepG2 Cells

Overview

Journal Eur Rev Med Pharmacol Sci

Specialties General Medicine
Pharmacology
Toxicology

Date 2017 Jul 26

PMID 28742211

Citations 2

Authors

Y Wang

Y-R Zhao

A-Y Zhang

J Ma

Z-Z Wang

X Zhang

Affiliations

Soon will be listed here.

Abstract

The article "Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells" by Y. Wang, Y.-R. Zhao, A.-Y. Zhang, J. Ma, Z.-Z. Wang, X. Zhang, published in Eur Rev Med Pharmacol Sci 2017; 21 (9): 2087-2097 has been withdrawn.

Citing Articles

Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.

Yan J, Cao J, Chen Z BMC Cancer. 2021; 21(1):175.

PMID: 33602168 PMC: 7891020. DOI: 10.1186/s12885-021-07886-6.

Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons.

Tipanee J, Di Matteo M, Tulalamba W, Samara-Kuko E, Keirsse J, Van Ginderachter J Mol Ther Nucleic Acids. 2020; 19:1309-1329.

PMID: 32160703 PMC: 7036702. DOI: 10.1016/j.omtn.2020.01.015.